Do you want to read an article? Please log in or register.
Safety and Efficacy of Submucosal Tunneling Endoscopic Septum Division for Esophageal Diverticulum
Further Publications
Related content
Esophagus Diseases
Long-Term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: a 4-Year, Phase 3, Open-Label Study
Clin Gastroenterol Hepatol
Dellon ES, Katzka DA, Mukkada VA, Collins MH, Falk GW, Richmond CA, Terreri B, Thakur M, Boules M, Goodwin B, Hirano I
doi: 10.1016/j.cgh.2024.12.024
COMMENTED
Esophagus Diseases
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: an Open-Label Extension Study
★ 3
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol
Biedermann L, Schlag C, Straumann A, Lucendo AJ, Miehlke S, Vieth M, Santander C, Ciriza de Los Rios C, Schmöcker C, Madisch A, Hruz P, Hayat J, von Arnim U, Bredenoord AJ, Schubert S, Halstead M, Pfurr S, Mueller R, Schoepfer AM, Attwood S, International EOS-2 Study Group
doi: 10.1016/j.cgh.2024.10.034
Inflammatory Bowel Disease
Comparative Efficacy and Safety of Endoscopic Modalities for Colorectal Cancer Screening in Inflammatory Bowel Disease: A Systematic Review and Network Meta-Analysis
Clin Gastroenterol Hepatol
Sinopoulou V, Nigam GB, Gordon M, Ganeshan M, Tokonyai MR, Dolwani S, Iacucci M, Rutter M, Subramanian V, Wilson A, British Society of Gastroenterology Colorectal IBD Surveillance Guideline Development Group, East JE
doi: 10.1016/j.cgh.2024.11.008
Esophagus DiseasesHepatology
Efficacy and safety of carvedilol in cirrhosis patients with new-onset uncomplicated ascites without high-risk esophageal varices. (CARVE-AS Trial)
Am J Gastroenterol
Khajuria R, Jindal A, Sharma MK, Arora V, Vyas AK, Kumar G, Sarin SK
doi: 10.14309/ajg.0000000000003650
COMMENTED
Esophagus Diseases
Clinical effectiveness of esophageal stricture dilation using an improved endoscopic attachment cap in adults with eosinophilic esophagitis
★ 2
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Endoscopy
Schoepfer AM, Biedermann L, Kreienbuehl A, Safroneeva E, Saner C, Schreiner P, Greuter T, Straumann A, Wakim J
doi: 10.1055/a-2606-7785
Inflammatory Bowel Disease
Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn's Disease of the Pouch
Inflamm Bowel Dis
Park S, Keyashian K, Ho A, Limsui D, Frost S, Vazquez R, Yang E, Ebriani J, Maas L, Parian A, Lazarev M, Parekh N, Sauk JS, Limketkai B
doi: 10.1093/ibd/izaf146
Inflammatory Bowel Disease
Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study
Lancet Gastroenterol Hepatol
Panaccione R, Vermeire S, Danese S, Higgins PDR, Lichtenstein GR, Nakase H, Glover S, Colombel JF, Eccleston J, Kujawski M, Remple V, Yao X, Geng Z, Palac H, Sharma D, Suravaram S, Schreiber S
doi: 10.1016/S2468-1253(25)00017-2
Inflammatory Bowel Disease
Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis
Adv Ther
Dignass A, Ainsworth C, Hartz S, Dunnewind N, Redondo I, Sapin C, Kroep S, Halfpenny N, Arcà E, Hoque S
doi: 10.1007/s12325-024-03003-8
Further Publications
Efficacy and safety of vedolizumab in elderly and younger patients with moderate-to-severe ulcerative colitis: a retrospective real-world study in China
BMC Gastroenterol
Zhang H, Ding XL, Xu YH, Wu J, Wang YY, Liu SX, Yan J, Liu H, Tian ZB, Liu AL
doi: 10.1186/s12876-025-04125-1